
17 September 2023 @ 14:20
Blog: Discovering targets and biomarkers for immunotherapies
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
17 September 2023 @ 14:20
Learn how tumor DNA- and RNA-sequencing enables the discovery of target antigens and response markers for immunotherapies
3 March 2023 @ 12:50
Learn how Amazentis leveraged omics analyses in a clinical trial for a postbiotic
13 September 2022 @ 14:10
Learn about Genevia Technologies' work with a research group studying the epigenetics of pain
27 May 2021 @ 16:18
Learn how machine learning enables risk stratification using high-throughput data
24 March 2021 @ 11:00
Learn how machine learning enables personalized clinical predictions
17 March 2021 @ 16:26
Learn how Genevia Technologies helped with FastEV's commercialization.
25 August 2020 @ 15:36
Learn about how KCT identified new biomarkers for a macrophage subtype of their interest.